Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?

Ayesha Karimi, Dan Lindfield Department of Ophthalmology, Royal Surrey County Hospital, Guildford, UK Purpose: To assess whether a first day review is needed following Xen surgery in glaucoma patients. Patients and methods: We performed a retrospective case note review of all Xen surgeries perform...

Full description

Bibliographic Details
Main Authors: Karimi A, Lindfield D
Format: Article
Language:English
Published: Dove Medical Press 2018-11-01
Series:Clinical Ophthalmology
Subjects:
Online Access:https://www.dovepress.com/is-a-day-1-postoperative-review-following-ab-interno-xen-gel-stent-sur-peer-reviewed-article-OPTH
id doaj-2c139f6b35264d34abd53142370c6b93
record_format Article
spelling doaj-2c139f6b35264d34abd53142370c6b932020-11-24T21:44:30ZengDove Medical PressClinical Ophthalmology1177-54832018-11-01Volume 122331233542341Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?Karimi ALindfield DAyesha Karimi, Dan Lindfield Department of Ophthalmology, Royal Surrey County Hospital, Guildford, UK Purpose: To assess whether a first day review is needed following Xen surgery in glaucoma patients. Patients and methods: We performed a retrospective case note review of all Xen surgeries performed across four centers between August 2015 and May 2017. Intraocular pressure (IOP), number of medications, complications, and all further procedures were recorded. Results: Two hundred and fifty-nine cases from 226 patients were analyzed, 78 of 259 cases (30.1%) had numerical hypotony (<6 mmHg) on Day 1, but 60 had resolved by Week 1. Zero cases of hypotony required intervention at Day 1. Two of 259 cases (0.8%) had transient IOP of ≥20 mmHg due to air bubble/iris blockage on Day 1 with one case (0.4%) requiring iris manipulation at the slit-lamp. One case (0.4%) required IOP lowering medications at Day 1. All other complications and interventions in our series occurred at 1 week or beyond. Day 1 IOP was not shown to be a reliable indicator for outcomes at Week 1 (r2=0.2155), Month 1 (r2=0.0574), or Month 12 (r2=0.1580). Conclusion: The presence of significant complications requiring intervention at Day 1 was 0%. Only one case (0.4%) required topical IOP lowering medication and one case (0.4%) needed stent manipulation at Day 1. Day 1 IOP is not a reliable indicator of long-term outcomes in Xen surgeries. Removing Day 1 follow-up would have been safe in our series and it may be more effective to perform the first postoperative review of Xen surgery at Week 1. Keywords: ab interno, MIGS, gel stent, open anglehttps://www.dovepress.com/is-a-day-1-postoperative-review-following-ab-interno-xen-gel-stent-sur-peer-reviewed-article-OPTHAb internoMIGSgel stentopen angle
collection DOAJ
language English
format Article
sources DOAJ
author Karimi A
Lindfield D
spellingShingle Karimi A
Lindfield D
Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?
Clinical Ophthalmology
Ab interno
MIGS
gel stent
open angle
author_facet Karimi A
Lindfield D
author_sort Karimi A
title Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?
title_short Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?
title_full Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?
title_fullStr Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?
title_full_unstemmed Is a Day 1 postoperative review following ab interno Xen gel stent surgery for glaucoma needed?
title_sort is a day 1 postoperative review following ab interno xen gel stent surgery for glaucoma needed?
publisher Dove Medical Press
series Clinical Ophthalmology
issn 1177-5483
publishDate 2018-11-01
description Ayesha Karimi, Dan Lindfield Department of Ophthalmology, Royal Surrey County Hospital, Guildford, UK Purpose: To assess whether a first day review is needed following Xen surgery in glaucoma patients. Patients and methods: We performed a retrospective case note review of all Xen surgeries performed across four centers between August 2015 and May 2017. Intraocular pressure (IOP), number of medications, complications, and all further procedures were recorded. Results: Two hundred and fifty-nine cases from 226 patients were analyzed, 78 of 259 cases (30.1%) had numerical hypotony (<6 mmHg) on Day 1, but 60 had resolved by Week 1. Zero cases of hypotony required intervention at Day 1. Two of 259 cases (0.8%) had transient IOP of ≥20 mmHg due to air bubble/iris blockage on Day 1 with one case (0.4%) requiring iris manipulation at the slit-lamp. One case (0.4%) required IOP lowering medications at Day 1. All other complications and interventions in our series occurred at 1 week or beyond. Day 1 IOP was not shown to be a reliable indicator for outcomes at Week 1 (r2=0.2155), Month 1 (r2=0.0574), or Month 12 (r2=0.1580). Conclusion: The presence of significant complications requiring intervention at Day 1 was 0%. Only one case (0.4%) required topical IOP lowering medication and one case (0.4%) needed stent manipulation at Day 1. Day 1 IOP is not a reliable indicator of long-term outcomes in Xen surgeries. Removing Day 1 follow-up would have been safe in our series and it may be more effective to perform the first postoperative review of Xen surgery at Week 1. Keywords: ab interno, MIGS, gel stent, open angle
topic Ab interno
MIGS
gel stent
open angle
url https://www.dovepress.com/is-a-day-1-postoperative-review-following-ab-interno-xen-gel-stent-sur-peer-reviewed-article-OPTH
work_keys_str_mv AT karimia isaday1postoperativereviewfollowingabinternoxengelstentsurgeryforglaucomaneeded
AT lindfieldd isaday1postoperativereviewfollowingabinternoxengelstentsurgeryforglaucomaneeded
_version_ 1716658108510502912